Cargando…

Assessment of the proposed intellectual property waiver as a mechanism to address the COVID-19 vaccine scarcity problem

Detalles Bibliográficos
Autores principales:	Barnes-Weise, Julia, Santos Rutschman, Ana, Adler, Reid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921581/ https://www.ncbi.nlm.nih.gov/pubmed/35140119 http://dx.doi.org/10.1136/jech-2021-218409

Ejemplares similares

Mixed response to COVID-19 intellectual property waiver
por: Zarocostas, John
Publicado: (2022)

What next for a COVID-19 intellectual property waiver?
por: Zarocostas, John
Publicado: (2021)

A Global Intellectual Property Waiver is Still Needed to Address the Inequities of COVID-19 and Future Pandemic Preparedness
por: Amin, Tahir, et al.
Publicado: (2022)

A Big Problem and Debate in COVID-19 Pandemics: Equitable and Effective Access of the COVID-19 Vaccines and Waiver of Intellectual Property
por: Kasapçopur, Özgür
Publicado: (2021)

Development of vaccines for influenza disease: Opportunity costs of the COVID-19 pandemic
por: Wiemken, Timothy L., et al.
Publicado: (2021)

US Support for a WTO Waiver of COVID-19 Intellectual Property
por: Contreras, Jorge L.
Publicado: (2021)

Time to boost COVID-19 vaccine manufacturing: The need for intellectual property waiver by big pharma
por: Okereke, M., et al.
Publicado: (2021)

Ensuring fair distribution of COVID-19 vaccines: is an intellectual waiver the answer?
por: Burki, Talha Khan
Publicado: (2021)

Scarcity, Property Rights, Irresponsibility: How Intellectual Property Deals with Neglected Tropical Diseases
por: Astone, Daniel Pinheiro
Publicado: (2022)

Intellectual property rights need to be subverted to ensure global vaccine access
por: Sariola, Salla
Publicado: (2021)

Vaccination Perceptions of College Students: With and without Vaccination Waiver
por: Jadhav, Emmanuel D., et al.
Publicado: (2018)

Addressing the pervasive scarcity of structural annotation in eukaryotic algae
por: Kwon, Taehyung, et al.
Publicado: (2023)

On the role of scarcity in marketing: Identifying research opportunities across the 5Ps
por: Roux, Caroline, et al.
Publicado: (2023)

Impact of the Maine Medicaid waiver for the mentally retarded
por: Coburn, Andrew F., et al.
Publicado: (1990)

Article Processing Charge Waiver Policies as a Barrier to Oncology Scholarship in Low- and Lower-Middle-Income Countries
por: Gardner, Ulysses G., et al.
Publicado: (2021)

Preparing humanitarians to address ethical problems
por: McGowan, Catherine R., et al.
Publicado: (2020)

A case study of the 1115 waiver using population health informatics to address disparities
por: Sitapati, Amy M, et al.
Publicado: (2020)

Inequities in Receipt of the North Carolina Medicaid Waiver Among Individuals with Intellectual Disability or Autism Spectrum Disorder
por: Franklin, Michelle S., et al.
Publicado: (2022)

The problem with relying on profit-driven models to produce pandemic drugs
por: Heled, Yaniv, et al.
Publicado: (2020)

How should we address the pipeline problem?
por: Braun, Hillary J.
Publicado: (2016)

Addressing the problem of obesity and associated cardiometabolic risk in black South African women – time for action!
por: Goedecke, Julia H.
Publicado: (2017)

Medical errors: how the US Government is addressing the problem
por: Schulman, Kevin A, et al.
Publicado: (2000)

Addressing the Missing Heritability Problem With the Help of Regulatory Features
por: Dong, Shan-Shan, et al.
Publicado: (2019)

Addressing malaria vector control challenges in South Sudan: proposed recommendations
por: Chanda, Emmanuel, et al.
Publicado: (2013)

Practical problems may preclude realization of this proposal
por: Della Mea, Vincenzo
Publicado: (2000)

Get waivered remote: Nationwide, remote DEA-x waiver course in response to COVID-19
por: Martin, Alister, et al.
Publicado: (2021)

Prioritizing COVID-19 vaccinations for individuals with intellectual and developmental disabilities
por: Hotez, Emily, et al.
Publicado: (2021)

Re-examining Vaccine Staggering Within Hesitancy Frameworks
por: Rutschman, Ana Santos, et al.
Publicado: (2021)

COVID-19 vaccination in the UK: Addressing vaccine hesitancy
por: Sonawane, Kalyani, et al.
Publicado: (2021)

The big picture in addressing vaccine hesitancy
por: Leask, Julie, et al.
Publicado: (2014)

On religious and secular exemptions: A case study of childhood vaccination waivers
por: Pierik, Roland
Publicado: (2017)

Addressing annotation and data scarcity when designing machine learning strategies for neurophotonics
por: Bouchard, Catherine, et al.
Publicado: (2023)

Home and Community-Based Services Waivers
por: Duckett, Mary Jean, et al.
Publicado: (2000)

Protecting intellectual property associated with Canadian academic clinical trials - approaches and impact
por: Ross, Sue, et al.
Publicado: (2012)

Addressing Vaccine Hesitancy in the Age of COVID-19
por: Fisher, Allison, et al.
Publicado: (2021)

Older adults and the disparity in oral health status; the problem and innovative ways to address it
por: Cardoso, Elaine O. C., et al.
Publicado: (2020)

Addressing Disability Inequities: Let’s Stop Admiring the Problem and Do Something about It
por: Rimmer, James H.
Publicado: (2022)

The Hourglass Model: Are There Structural Problems with the Scarcity of Positive Results for Flexible ACT?#
por: Norlander, Torsten, et al.
Publicado: (2015)

Maintaining Warp Speed: Policy Requirements for a Just-in-Time, Capability-Based, Scalable Medical Countermeasure Research and Development Enterprise
por: O'Leary, Colin N., et al.
Publicado: (2023)

State Health Reform and the Role of 1115 Waivers
por: Riley, Trish
Publicado: (1995)

Cannot write session to /tmp/vufind_sessions/sess_md7hm0dpnl0v6a7fnh6cpfkgkm